Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief Executive Officer, and will oversee the Company’s gene therapy programs. Dr. Addis leads a growing organization and will build on the ...
STATE COLLEGE, Penn., Aug. 23, 2021 /PRNewswire/ -- NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback